HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31

Cellyan Biotechnology Co., Ltd

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026

$0.11+0.00 (+1.81%)

Close on Oct 19, 2026

Community

Notes and questions about Cellyan Biotechnology from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Cellyan Biotechnology's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HKPD.

Revenue growth-33.9% · median -38.6%

Gross margin10.3% · median 10.3%

Operating margin-17.8% · median -100.8%

Net margin-8.5% · median -159.7%

Advertisement
300 × 250